Aktuális sajtó tartalmak és illusztrációs fotók

1 648 találat
  • / 42
  • kép/oldal:
RF
Tallinn, Estonia - June 15, 2025: bloodthinner Lixiana tablets by Daiichi Sankyo.-stock-foto
RF
Tallinn, Estonia - June 15, 2025: bloodthinner Lixiana tablets by Daiichi Sankyo.-stock-foto
RF
Pregnant woman administer heparin to herself to treat her thrombophilia.-stock-foto
RF
Pregnant woman administer heparin to herself to treat her thrombophilia.-stock-foto
RF
Pregnant woman administer heparin to herself to treat her thrombophilia.-stock-foto
RF
Pregnant woman administer heparin to herself to treat her thrombophilia.-stock-foto
RF
A pregnant woman using injection to treat her thrombophilia.-stock-foto
RF
Whole blood in the test tube before and after Centrifugation. Blood components, Plasma, Red blood cells, and the Buffy coat like Leukocytes and platel-stock-foto
RF
Prague, Czech Republic - June 28 2025: PRADAXA box of medication with Dabigatran etexilate active substance by Boehringer Ingelheim, used for stroke p-stock-foto
RF
Prague, Czech Republic - June 28 2025: PRADAXA box of medication with Dabigatran etexilate active substance by Boehringer Ingelheim, used for stroke p-stock-foto
RF
Prague, Czech Republic - June 28 2025: PRADAXA box of medication with Dabigatran etexilate active substance by Boehringer Ingelheim, used for stroke p-stock-foto
RF
Prague, Czech Republic - June 28 2025: PRADAXA box of medication with Dabigatran etexilate active substance by Boehringer Ingelheim, used for stroke p-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic -May 6, 2025: Warfarine medication bottle used for anticoagulant therapy.-stock-foto
RF
Prague, Czech Republic - June 28 2025: PRADAXA box of medication with Dabigatran etexilate active substance by Boehringer Ingelheim, used for stroke p-stock-foto
RF
Prague, Czech Republic - June 28 2025: PRADAXA box of medication with Dabigatran etexilate active substance by Boehringer Ingelheim, used for stroke p-stock-foto
RF
Prague, Czech Republic - June 28 2025: PRADAXA box of medication with Dabigatran etexilate active substance by Boehringer Ingelheim, used for stroke p-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto
RF
Prague,Czech Republic-April 8 2025: Bayer Xarelto tablets containing rivaroxaban anticoagulant for thrombosis prevention and stroke risk reduction.-stock-foto